Carl W. Ehmann
Direttore/Membro del Consiglio presso MUSC Foundation for Research Development
Profilo
Carl W.
Ehmann is currently the Director at MUSC Foundation for Research Development and the Treasurer & Director at Guadalupe Center, Inc. Previously, he worked as a Director at Barrier Therapeutics, Inc. from 2004 to 2008, Director-Clinical Research & Dermatology at Hoffman-LaRoche F & Co. AG, VP-Pharmaceutical Research & Development at Bristol Myers Squibb Co., and Executive VP, Head-Global Research & Development at Johnson & Johnson.
He received his undergraduate and doctorate degrees from State University of New York at Buffalo.
Posizioni attive di Carl W. Ehmann
| Società | Posizione | Inizio |
|---|---|---|
| MUSC Foundation for Research Development | Direttore/Membro del Consiglio | - |
Guadalupe Center, Inc.
 Guadalupe Center, Inc. Services to the Health IndustryHealth Services Guadalupe Center, Inc. provides educational, social, and other support programs and resources for the children and families of Immokalee. The company was founded in 1982 and is headquartered in Immokalee, FL. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Carl W. Ehmann
| Società | Posizione | Fine |
|---|---|---|
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Direttore/Membro del Consiglio | 04/08/2008 |
| JOHNSON & JOHNSON | Direttore Tecnico/Scientifico/R&S | - |
| BRISTOL-MYERS SQUIBB COMPANY | Direttore Tecnico/Scientifico/R&S | - |
Hoffman-LaRoche F & Co. AG
 Hoffman-LaRoche F & Co. AG Miscellaneous Commercial ServicesCommercial Services Hoffman-LaRoche F & Co. AG is a Swiss company. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Carl W. Ehmann
| State University of New York at Buffalo | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| Aziende private | 4 |
|---|---|
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
| MUSC Foundation for Research Development | |
Hoffman-LaRoche F & Co. AG
Hoffman-LaRoche F & Co. AG Miscellaneous Commercial ServicesCommercial Services Hoffman-LaRoche F & Co. AG is a Swiss company. | Commercial Services |
Guadalupe Center, Inc.
Guadalupe Center, Inc. Services to the Health IndustryHealth Services Guadalupe Center, Inc. provides educational, social, and other support programs and resources for the children and families of Immokalee. The company was founded in 1982 and is headquartered in Immokalee, FL. | Health Services |
- Borsa valori
- Insiders
- Carl W. Ehmann
